-

ValGenesis to Exhibit Smart GxP™ at 2026 ISPE Europe Annual Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, will exhibit its Smart GxP™ platform at the ISPE Europe Annual Conference, April 20-22, in Copenhagen, Denmark.

Attendees can visit Booth No. 807 to learn more.

Share

As pharmaceutical and biotechnology manufacturers navigate increasing regulatory expectations, operational complexity, and the integration of artificial intelligence into GxP environments, ValGenesis product specialists will be on-site to connect with pharmaceutical engineering and quality professionals and discuss strategies for modernizing validation and scaling AI-enabled quality systems in regulated environments.

The company will feature its Validation Lifecycle Suite and Process Lifecycle Suite, scalable solutions that unify validation and process development under a single solution stack—the ValGenesis Smart GxP™ platform. Powered by AI, the platform connects R&D, validation, and commercial manufacturing —enabling life sciences organizations to reduce cycle times, improve inspection readiness, surface predictive insights, and move from reactive compliance to proactive performance management.

“Artificial intelligence is redefining how pharmaceutical companies approach validation and quality,” said David Medina, chief marketing officer at ValGenesis. “At ISPE Europe, we look forward to discussing how compliant, enterprise-grade AI can transform validation from a documentation exercise into a strategic driver of speed, insight, and competitive advantage.”

Attendees can visit Booth No. 807 to learn more.

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit www.valgenesis.com.

Contacts

Further information
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

ValGenesis Inc.


Release Versions

Contacts

Further information
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis Inc.

Leading Public Health Organization Implements ValGenesis Platform

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in enterprise digital validation, announced that a leading public health organization has gone live with ValGenesis, marking a significant milestone in its mission to strengthen global health research and preparedness. The organization conducts research focused on addressing infectious diseases and emerging global health challenges, contributing to scientific advancement and improved public health outcomes worldwide. The...

Ulrich Medical Selects ValGenesis iVal™ for SAP-Driven CSV Upgrade

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the market leader in enterprise digital validation, announced that Ulrich Medical has selected ValGenesis iVal™ to modernize computer system validation (CSV) processes in support of its broader digital transformation and upcoming SAP implementation. The Germany-based medical device company will replace manual validation processes with a digital approach to manage increased CSV activity associated with the SAP rollout. The initial deployment...

ValGenesis Brings Global Life Sciences Community Together at ValConnect Innovation Days

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the global leader in enterprise digital validation, successfully concluded two ValConnect Innovation Day events in Lisbon, Portugal, and Research Triangle Park (RTP), North Carolina, highlighting the growing focus on compliance-ready artificial intelligence, digital validation, and process lifecycle innovation across the life sciences industry. The Lisbon event featured customer presentations and peer discussions focused on digital transfo...
Back to Newsroom